申请人:Schering Aktiengesellschaft
公开号:US04987146A1
公开(公告)日:1991-01-22
N-hetaryl imidazole derivatives of general Formula I ##STR1## are disclosed in which Het represents an optionally substituted monocyclic or bicyclic heteroaromate, R.sup.3 represents hydrogen, a straight or branched C.sub.1-6 -alkyl group, or a C.sub.1-6 -alkoxy-alkyl group, and R.sup.4 represents --COOR.sup.5 --CONR.sup.6 R.sup.7 --CN, ##STR2## with R.sup.5 meaning hydrogen, a straight or branched C.sub.1-6 -alkyl group, R.sup.6 and R.sup.7 are the same of different and represent hydrogen or a straight, branched, or cyclic alkyl group with up to 7 carbon atoms or, together with the nitrogen atom, form a saturated five or six ring optionally containing another heteroatom and R.sup.8 means hydrogen or a straight, branched or cyclic alkyl group with up to 7 carbon atoms.
公开了通式I的N-杂环咪唑衍生物,其中Het代表可选择取代的单环或双环杂芳烃,R.sup.3代表氢、直链或支链的C.sub.1-6-烷基基团,或C.sub.1-6-烷氧基烷基基团,R.sup.4代表--COOR.sup.5--CONR.sup.6R.sup.7--CN,其中R.sup.5表示氢、直链或支链的C.sub.1-6-烷基基团,R.sup.6和R.sup.7相同或不同,表示氢或直链、支链或环状烷基基团,含有最多7个碳原子,或者与氮原子一起形成一个饱和的五元或六元环,可选择包含另一个杂原子,R.sup.8表示氢或含有最多7个碳原子的直链、支链或环状烷基基团。